Entry Point Capital, LLC 10x Genomics, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 872 shares of TXG stock, worth $17,457. This represents 0.02% of its overall portfolio holdings.
Number of Shares
872
Previous 7,589
88.51%
Holding current value
$17,457
Previous $285 Million
94.05%
% of portfolio
0.02%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
284Shares Held
96.2MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$204 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$186 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$128 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$123 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$123 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.9B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...